Author

Iffat Khanum

Aga Khan university hospital - Cited by 127 - emerging infections - fungal infection - infection control

Biography

Iffat Khanum is currently working as a Professor in the Department of Internal Medicine. Her research interests includes Medicine. She is serving as an editorial member and reviewer of several international reputed journals. Iffat Khanum has successfully completed her Administrative responsibilities. Iffat Khanum has authored of many research articles/books related toInternal Medicine.  
Title
Cited by
Year
Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
KI Masood, M Yameen, J Ashraf, S Shahid, SF Mahmood, A Nasir, ...Scientific reports 11 (1), 22958, 2021202
31
2021
Clinical characteristics and outcomes of COVID-19: Experience at a major tertiary care center in Pakistan
N Nasir, K Habib, I Khanum, N Khan, ZA Muhammad, SF MahmoodJournal of Infection in Developing Countries 15 (4), 480, 2021202
17
2021
Role of awake prone positioning in patients with moderate-to-severe COVID-19: an experience from a developing country
I Khanum, F Samar, Y Fatimah, A Safia, A Adil, H Kiren, N Nosheen, ...Monaldi Archives for Chest Disease 91 (2), 2021202
14
2021
Enterococcal meningitis/ventriculitis: A tertiary care experience
I Khanum, S Anwar, A FarooqueAsian Journal of Neurosurgery 14 (01), 2-5, 2019201
10
2019
Knowledge, attitude and perception survey of doctors regarding antibiotic use and resistance in Karachi, Pakistan
H Ahmed, S Bhimani, I Khanum, A Khan, A Khetpal, MA Abbas, F Godil, ...JPMA. The Journal of the Pakistan Medical Association 70 (6), 23, 2020202
10
2020
Stenotrophomonas maltophilia meningitis-a case series and review of the literature
I Khanum, A Ilyas, F AliCureus 12 (), 2020202
10
2020
Tocilizumab for COVID-19 acute respiratory distress syndrome: outcomes assessment using the WHO ordinal scale
N Nasir, F Mahmood, K Habib, I Khanum, B JamilCureus 12 (12), 2020202
7
2020
Treatment of ARDS and hyperinflammation in COVID-19 with IL-6 antagonist Tocilizumab: a tertiary care experience from Pakistan
Treatment of ARDS and hyperinflammation in COVID-19 with IL- antagonist Tocilizumab: a tertiary care experience from PakistanN Nasir, SF Mahmood, K Habib, I Khanum, B JamilMedRxiv, 2020.0. 23.20134072, 2020202
6
2020
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
I Khanum, L Kumar, S Awan, B JamilClinical and experimental vaccine research 10 (3), 276, 2021202
4
2021
Comparison of clinical characteristics and outcomes between COVID-19 pneumonia and H1N1 influenza
N Nasir, I Khanum, K Habib, R Ahmed, M Hussain, Z Hasan, M IrfanAdvances in respiratory medicine 89 (), 254-261, 2021202
3
2021
Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in an immunocompetent patient: A case report and review of literature
MZ Mushtaq, SBZ Mahmood, N Nasir, MS Rashid, M Irshad, K Habib, ...Current Medical Mycology 6 (), 65, 2020202
3
2020
Tuberculosis in solid organ transplantation: insights from TB endemic areas
N Nasir, S Sarfaraz, I Khanum, T Ansari, A Nasim, SK Dodani, S LuxmiCurrent Infectious Disease Reports 3, 1-13, 010
2
2021
Predictors of severity and mortality of COVID-19 at a tertiary care center in a Lower-middle income country
N Nasir, K Habib, I Khanum, N Khan, ZA Muhammad, SF MahmoodAuthorea Preprints, 000
2
2020
Transcriptomic profiling of disease severity in patients with COVID-19 reveals role of blood clotting and vasculature related genes
KI Masood, SF Mahmood, S Shahid, N Nasir, N Ghanchi, A Nasir, B Jamil, ...medRxiv, 00.06. 18.013571, 000
2
2020
Predictors of mortality in hospitalized patients with influenza: a five-year experience from a tertiary care centre in Pakistan
I Khanum, AS Ahmed, S Awan, S Banu, B JamilMonaldi Archives for Chest Disease 90 (4), 69, 000
2
2020
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase /3, randomized, third-party double-blind clinical trialH Bian, L Chen, ZH Zheng, XX Sun, JJ Geng, R Chen, K Wang, X Yang, ...Signal transduction and targeted therapy 8 (1), 46, 030
2
2023
Clinical Characteristics and Risk Factors of Candidemia in Tertiary Care Hospital
I Khanum, SF Mahmood, H Waqar, S AwanInfectious Diseases Journal of Pakistan. 24 (3), 859, 20520
1
2015
Post-COVID-19 sequelae of the respiratory system. A single-centre experience reporting the compromise of the airway, alveolar and vascular components
Post-COVID-9 sequelae of the respiratory system. A single-centre experience reporting the compromise of the airway, alveolar and vascular componentsN Iqbal, I Khanum, MAI Kazi, SU Riaz, UA Khawaja, S Awan, M Irfan, ...Monaldi Archives for Chest Disease 93 (3), 2023202
1
2023

Referred From: https://scholar.google.com/citations?hl=en&user=_goX1rUAAAAJ

Cited by
Citations 127
h-index 7
i10-index 6
Recommended Journals
Open Access Journals